YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

HKEX:1558.HK

8.29 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 1,674.4133,781.609923.543859.0971,131.1211,327.6422,044.9673,346.182,779.1382,857.444593.7461,355.903887.183988.0921,212.0721,470.0181,353.651689.64886.554
Short Term Investments 18.68619.11829000000010000346.519475.548238.98803300
Cash and Short Term Investments 1,674.4133,781.6091,213.543859.0971,131.1211,327.6422,044.9673,346.182,779.1383,217.444593.7461,355.9031,233.7021,463.641,451.061,470.0181,386.651689.64886.554
Net Receivables 2,072.6111,113.2271,005.817726.831479.041248.864460.509908.0572,196.3811,686.403969.763895.989721.91473.834328.738325.991250.094256.434133.128
Inventory 409.05353.545315.027315.321279.696392.077378.268349.746206.62165.027195.999110.01299.671105.667116.162123.249162.021174.36203.834
Other Current Assets 1,896.9821,365.5292,769.633300.037167.518306.507380.366103.894148.57405.35625.85645.72613.3475.1765.50834.74811.15835.57854.729
Total Current Assets 6,053.0566,613.915,014.022,201.2862,057.3762,275.093,264.114,707.8775,330.7095,214.231,785.3642,407.632,068.632,048.3171,901.4681,954.0061,809.9241,156.02478.245
Non-Current Assets:
Property, Plant & Equipment, Net 3,849.6683,560.6523,518.7653,246.9673,216.5553,013.122,835.7062,446.9372,025.5071,554.631,351.479955.44670.225518.144495.682470.475462.5456.435463.635
Goodwill 00075.89675.89675.89675.89675.89675.89675.89675.89675.89675.89675.89600000
Intangible Assets 2,571.7611,754.8271,782.3831,957.0012,070.6441,822.5741,536.43775.311534.047562.546369.133303.518317.013330.50481.76782.73483.69900
Goodwill and Intangible Assets 2,571.7611,754.8271,782.3832,032.8972,146.541,898.471,612.326851.207609.943638.442445.029379.414392.909406.481.76782.73483.69900
Long Term Investments 32.15812.3455,160.5391,789.6211,789.6214,786.1724,407.3873,167.5262,539.6892,127.3121,764.421,289.7611,034.891908.704402.5370.135368.40900
Tax Assets 237.686120.066140.609106.65165.318125.41840.645130.61895.76165.7632.08845.09328.24315.8411.41517.60610.39200
Other Non-Current Assets 0-120.066-5,301.148-106.651-65.318-4,911.59-4,448.032-3,298.144-2,635.45-2,193.072-1,796.508-1,334.854-1,063.134-924.544-495.682-470.475-462.514.7247.651
Total Non-Current Assets 6,691.2735,327.8245,301.1487,069.4857,152.7164,911.594,448.0323,298.1442,635.452,193.0721,796.5081,334.8541,063.134924.544495.682470.475462.5471.159471.286
Total Assets 12,744.32913,444.19611,889.810,813.72110,541.5818,913.6739,561.26710,460.0059,912.3399,131.2514,560.944,572.3213,775.9753,491.0922,831.1092,781.9042,577.4151,627.179949.531
Liabilities & Equity:
Current Liabilities:
Account Payables 200.088187.387178.614181.137193.473145.156244.942337.152184.697162.95880.55494.76659.86728.75624.30636.70233.41127.38253.744
Short Term Debt 2,319.8773,972.5863,130.3062,895.30848.47713.0752,820.804357.296132.66356.23553.3991010707032.5105322.436270
Tax Payables 297.343169.009160.59821.607250.75510.66527.56443.849272.214155.21697.677130.743146.71950.38945.1347.52722.18300
Deferred Revenue -0.359-3,972.586-3,130.306-2,895.308-48.477-13.075-2,820.804-357.296-132.66-356.235-53.399-10-10-70-70-32.5-10500
Other Current Liabilities 1,812.6145,470.4094,762.1673,792.1691,044.591959.6233,916.2712,095.912,126.9521,810.076732.244845.374580.88465.194259.975291.796237.755128.167122.246
Total Current Liabilities 4,332.225,657.7964,940.7813,973.3061,238.0641,104.7794,161.2132,433.0622,311.6491,973.034812.798940.14640.747493.95284.281328.498271.166477.985445.99
Non-Current Liabilities:
Long Term Debt 289.451507.083691.529661.9073,145.0253,072.564189.8532,950.3272,902.62,825.580101020209090122.5145
Deferred Revenue Non-Current 187.145185.392187.489190.208137.73139.648106.542102.74474.93567.07469.21462.45464.64266.83269.02171.21173.400
Deferred Tax Liabilities Non-Current -187.145321.691504.04471.6993,007.2952,932.91683.3112,847.5832,827.6652,758.5060-52.454-54.642-46.832-49.02118.78916.600
Other Non-Current Liabilities 187.145-507.083-691.529-661.907-3,145.025-3,072.564-189.853-2,950.327-2,902.6-2,825.580-10-10-20-20-90-9079.09781.286
Total Non-Current Liabilities 476.596507.083691.529661.9073,145.0253,072.564189.8532,950.3272,902.62,825.5869.214101020209090201.597226.286
Total Liabilities 4,808.8166,350.2715,819.7994,825.4214,520.8194,316.9914,457.6085,486.1335,289.1844,865.688882.0121,012.594715.389580.782373.302489.709434.566679.582672.276
Equity:
Preferred Stock 439.987000000000000000000
Common Stock 879.968879.968879.968879.968879.968879.968879.968879.968448.82452.023452.023452.023452.023452.023450.823450.823450.659360.527170.8
Retained Earnings 3,947.1443,424.0022,394.5072,285.1062,317.90402,905.5532,771.6032,726.0722,239.2991,505.3551,378.172879.235714.803548.55382.938235.576123.07498.391
Accumulated Other Comprehensive Income/Loss 2,668.4142,610.4092,610.4092,610.4092,610.4093,504.1071,105.5821,108.4681,375.8721,476.5781,476.5781,476.5781,476.5781,476.5781,458.4341,458.4341,456.614463.9968.064
Other Total Stockholders Equity 00000000-142.209-105.515-0-00000000
Total Shareholders Equity 7,935.5136,914.3795,884.8845,775.4835,808.2814,384.0754,891.1034,760.0394,408.5554,062.3853,433.9563,306.7732,807.8362,643.4042,457.8072,292.1952,142.849947.597277.255
Total Equity 7,935.5137,093.9256,070.0015,988.36,020.7624,596.6825,103.6594,973.8724,623.1554,265.5633,678.9283,559.7273,060.5862,910.312,457.8072,292.1952,142.849947.597277.255
Total Liabilities & Shareholders Equity 12,744.32913,444.19611,889.810,813.72110,541.5818,913.6739,561.26710,460.0059,912.3399,131.2514,560.944,572.3213,775.9753,491.0922,831.1092,781.9042,577.4151,627.179949.531